US FDA Likely To Embrace In-Person, Remote Combo For Facility Inspections Going Forward
Executive Summary
System likely will evolve as post-pandemic world unfolds, but adds to list of agency programs expecting to continue using virtual platforms once in-person activities are no longer restricted by COVID-19.